Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 1 - 10 of 422

Selected Filters:
21 May 2026

Kenya Integrated Guidelines for Prevention, Treatment and Management of HIV, Sexually Transmitted Infections and Viral Hepatitis, 2026

These clinical guidelines, developed by Kenya’s Ministry of Health in 2026, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR).

Normative Guidance/Policies

Document
19 May 2026

Global PrEP Tracker

Last update: April 2026 Visit data.prepwatch.org for a dynamic map-based tool to explore trends in PrEP use globally, including by country, product, and time period. Comprehensive datasets are available to download by clicking “download data” in the upper righthand corner. For any questions, contact [email protected]. Introduction to the Global PrEP Tracker

Monitoring & Evaluation, Service Delivery

External Link
14 May 2026

Advancing Equitable Access to Lenacapavir for PrEP (Africa Focus)

The recent significant changes to global health funding have severely impacted HIV prevention services for those who need them most, in particular key populations (KPs). Already, some countries are seeing concerning trends in data suggesting a resurgence in new infections. At the same time, powerful new HIV prevention options are now a reality, though their…

Community/Advocacy, Demand Creation/Marketing, Service Delivery

Event
17 April 2026

Zambia PrEP Training Materials for Clinicians and Community Mobilisers

These materials, developed by Zambia’s Ministry of Health, can be used to train clinicians and mobilisers in delivery of PrEP methods, including injectable lenacapavir (LEN), cabotegravir (CAB), the dapivirine vaginal ring (DVR), the Dual Prevention Pill (DPP), and oral PrEP.

Normative Guidance/Policies, Service Delivery

Document
17 April 2026

Zambia Guidelines for Pre and Post-Exposure Prophylaxis for HIV Infection, 2025

These clinical guidelines, developed by Zambia’s Ministry of Health in 2025, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR), as well as the Dual Prevention Pill and oral PrEP.

Normative Guidance/Policies

Document
31 March 2026

LEN Learning Clinic: Innovations in Service Delivery & Facility-Level Implementation

This interactive learning clinic brings together governments, implementing partners, and technical assistance teams to share and discuss early insights from LEN introduction — with a focus on practical service delivery innovations from the field. This will be interactive— come ready to engage. Featured Speakers: Dr Chimika Phiri, Ministry of Health, Zambia- Early insights from Zambia’s…

Service Delivery

Event
6 March 2026

Bridging HIV Prevention and Sexual Reproductive Health Services in the Context of Multi-method PrEP: A qualitative study exploring Provider Perceptions in South Africa

This article from Frontiers in Reproductive Health describes a study examining health care providers’ perspectives on the integration of PrEP and sexual and reproductive health services in South Africa.

Service Delivery

External Link
26 February 2026

Early Experiences with Usage of Long-acting Injectable Cabotegravir among Adults in Rural Ugandan and Kenyan Communities: Qualitative research from the SEARCH “Dynamic Choice HIV Prevention” intervention trials

This article from Journal of the International AIDS Society describes the results of a qualitative study exploring experiences with injectable cabotegravir (CAB for PrEP) among adults participating in the SEARCH Dynamic Choice HIV Prevention (DCP) trial in rural Kenya and Uganda, which evaluated HIV prevention uptake through a structured, person-centred DCP model.

Community/Advocacy, Research, Service Delivery

External Link
9 February 2026

PrEP Clinical Reporting Tools

This suite of clinical reporting forms, developed by South Africa’s National Department of Health, can be used for PrEP reporting, including injectable lenacapavir (LEN). The download folder includes forms for PrEP initiation, continuation, pregnancy outcome reporting, and seroconversion reporting.

Monitoring & Evaluation

Document
9 February 2026

Lenacapavir Training Videos

These videos, developed by South Africa’s National Department of Health, can be used to train providers offering injectable lenacapavir (LEN) for PrEP, and include modules on screening, initiation, counselling, follow-up, side effects, special considerations, and reporting.

Service Delivery

External Link